What If You Could Eliminate Joint Replacements And Own the Breakthrough That Makes It Possible?*

Let me ask you something personal.

Do you know someone, maybe even you, who struggles to bend over or get out of a chair without wincing? Who avoids stairs? Who jokes about being “bone-on-bone,” but deep down is terrified of that looming phrase: joint replacement surgery?

Now think about this: How far would you go to help them avoid it? And what if you could be part of the solution and own a piece of it, too?

Because that’s exactly what’s happening right now.


This Isn’t Just About Investment. It’s About Impact.

In a recent conversation, Kevin O’Leary (Mr. Wonderful) sat down with Joey Bose, CEO of Cytonics, to talk about what this small, scrappy biotech company is doing.

Kevin didn’t just endorse it. He also asked the hard questions. But by the end of it?

He was asking how to get the therapy for his own hip.

Why?

Because the science isn’t science fiction. It’s real. And for 10,000+ patients, including professional MMA athletes, it’s already changed lives.


The Problem Is Massive. And You Probably Know Someone Living With It.

Over 500 million people suffer from osteoarthritis (OA); a painful, progressive disease that literally eats away at your joints.

The typical path?

• Years of pain pills and steroid injections
• Insurance battles
• Then surgery: knees, hips, shoulders, pick your joint
• Months of recovery
• And tens of thousands in cost

Let’s be real: nobody wants that.

Kevin O’Leary didn’t. And neither do the 6,000+ people who’ve already invested in Cytonics.


So What Makes Cytonics Different?

Here’s the short version:

• They’re not trying to mask symptoms.
• They’ve developed a drug, CYT-108, designed to go straight to the root cause.
• It’s based on a natural protein (A2M) your body already makes.
• But most people can’t get enough of it into their joints to matter.
• So Cytonics engineered a stronger, smarter version, and built a way to deliver it directly to the source of pain.

Dr. Scuderi, the company’s founder (and yes, a black belt in Brazilian jiu-jitsu), figured this out after years as a spine surgeon. He saw firsthand what pain looks like. He wasn’t okay with band-aids.

So, like any good problem solver, he said: There has to be a better way.

And he found it.


This Is More Than Hope. It’s Data.

• FDA clearance for their first-gen A2M treatment
• 10,000+ patients already helped
• 25+ global patents
• $25 million raised, including support from professional athletes
• Phase 1 human trials completed for CYT-108, no major safety issues reported
• Phase 2 is next, and that’s when things get interesting

Joey, the CEO, explained it like this: “Big Pharma tries to fight this with one molecule, one target. That’s not enough. Osteoarthritis is like Medusa, you’ve got to cut off all the heads.”

And CYT-108 is designed to do exactly that.


Why This Matters for You

Here’s the wild part: Cytonics didn’t raise money from Wall Street or venture capitalists.

They went straight to the people. To folks who live with this pain. Or know someone who does. Or just want to invest in something real.

People like you.

Over 6,000 everyday investors have already gotten in. Some invested $500. Others, $25,000.

Not because they’re biotech experts. But because they see:

• A real problem
• A clear solution
• And a chance to be part of something that matters
  

What You’re Standing For (and What You’re Standing to Gain)

This is about more than financial upside. But let’s be honest, that matters too.

Because the osteoarthritis treatment market is worth $393 billion. The biologics market? $581 billion by 2026.

And if this drug works as intended? It could change how the world treats pain.

Yes, you’re investing in a company.

But you’re also investing in:

• Fewer surgeries
• Less suffering
• A system that treats causes, not just symptoms

That’s the kind of win-win most investors dream about.


So, Back to That Question:

• Would you help someone you love avoid surgery?
• Would you want them to live with less pain?
• Would you want to be part of the reason that future exists?

If your answer is yes… then here’s your next step: